Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9701 |
High Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.9349 |
High Similarity |
NPD6797 |
Phase 2 |
0.9294 |
High Similarity |
NPD7251 |
Discontinued |
0.924 |
High Similarity |
NPD7808 |
Phase 3 |
0.9231 |
High Similarity |
NPD7054 |
Approved |
0.9176 |
High Similarity |
NPD7472 |
Approved |
0.9064 |
High Similarity |
NPD7074 |
Phase 3 |
0.9059 |
High Similarity |
NPD3818 |
Discontinued |
0.9053 |
High Similarity |
NPD6166 |
Phase 2 |
0.9053 |
High Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.9053 |
High Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.881 |
High Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8802 |
High Similarity |
NPD3817 |
Phase 2 |
0.8786 |
High Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.875 |
High Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8743 |
High Similarity |
NPD2801 |
Approved |
0.869 |
High Similarity |
NPD5402 |
Approved |
0.8686 |
High Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8639 |
High Similarity |
NPD3882 |
Suspended |
0.8571 |
High Similarity |
NPD1934 |
Approved |
0.8516 |
High Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.848 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8412 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8362 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8353 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8333 |
Intermediate Similarity |
NPD1653 |
Approved |
0.8324 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8323 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8304 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8274 |
Intermediate Similarity |
NPD5403 |
Approved |
0.8235 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8207 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.8204 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8204 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8202 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.8171 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8155 |
Intermediate Similarity |
NPD5401 |
Approved |
0.8081 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8079 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.8079 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8073 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.8059 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.8045 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8043 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.8034 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.8033 |
Intermediate Similarity |
NPD8312 |
Approved |
0.8033 |
Intermediate Similarity |
NPD8313 |
Approved |
0.8022 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.8 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7989 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7976 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7941 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7921 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7919 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7917 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7917 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7917 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7917 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7917 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7917 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7917 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7889 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7886 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7841 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7836 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7828 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7828 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7821 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7821 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7809 |
Intermediate Similarity |
NPD919 |
Approved |
0.7809 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7798 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7778 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7755 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7755 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7738 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7738 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7727 |
Intermediate Similarity |
NPD37 |
Approved |
0.7706 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7704 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7704 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7704 |
Intermediate Similarity |
NPD7698 |
Approved |
0.77 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.77 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7697 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7697 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7697 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7679 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7674 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7668 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7656 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7656 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7654 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7638 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7637 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7633 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7619 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7598 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7584 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7545 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7545 |
Intermediate Similarity |
NPD1933 |
Approved |
0.754 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7538 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7538 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7536 |
Intermediate Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.7526 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7525 |
Intermediate Similarity |
NPD7801 |
Approved |
0.75 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7487 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7487 |
Intermediate Similarity |
NPD8319 |
Approved |
0.7485 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7475 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7471 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7442 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.744 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7425 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7413 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7399 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7381 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7381 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7381 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7381 |
Intermediate Similarity |
NPD943 |
Approved |
0.7368 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7344 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7294 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7264 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7263 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7263 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7262 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7262 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7247 |
Intermediate Similarity |
NPD920 |
Approved |
0.7245 |
Intermediate Similarity |
NPD6214 |
Clinical (unspecified phase) |
0.7245 |
Intermediate Similarity |
NPD6213 |
Phase 3 |
0.7245 |
Intermediate Similarity |
NPD6212 |
Phase 3 |
0.7236 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7232 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7232 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7232 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7232 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7225 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7219 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7217 |
Intermediate Similarity |
NPD5619 |
Clinical (unspecified phase) |
0.7211 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7209 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7209 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7206 |
Intermediate Similarity |
NPD7585 |
Approved |
0.7202 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7157 |
Intermediate Similarity |
NPD7583 |
Approved |
0.7143 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7135 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7114 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7108 |
Intermediate Similarity |
NPD7211 |
Clinical (unspecified phase) |
0.7105 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7083 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7072 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7065 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7059 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7045 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7041 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7029 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7022 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7011 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7011 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.6995 |
Remote Similarity |
NPD7039 |
Approved |
0.6995 |
Remote Similarity |
NPD7038 |
Approved |
0.6984 |
Remote Similarity |
NPD5242 |
Approved |
0.6983 |
Remote Similarity |
NPD7390 |
Discontinued |
0.6982 |
Remote Similarity |
NPD9494 |
Approved |
0.6968 |
Remote Similarity |
NPD8127 |
Discontinued |
0.6964 |
Remote Similarity |
NPD1203 |
Approved |
0.6949 |
Remote Similarity |
NPD6674 |
Discontinued |
0.6949 |
Remote Similarity |
NPD2800 |
Approved |
0.6949 |
Remote Similarity |
NPD1652 |
Phase 2 |
0.6941 |
Remote Similarity |
NPD4908 |
Phase 1 |
0.6936 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6936 |
Remote Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.6932 |
Remote Similarity |
NPD2344 |
Approved |
0.691 |
Remote Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.6902 |
Remote Similarity |
NPD6385 |
Approved |
0.6902 |
Remote Similarity |
NPD6386 |
Approved |
0.6888 |
Remote Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.6886 |
Remote Similarity |
NPD9269 |
Phase 2 |
0.6881 |
Remote Similarity |
NPD8058 |
Clinical (unspecified phase) |
0.6881 |
Remote Similarity |
NPD8059 |
Phase 3 |
0.6878 |
Remote Similarity |
NPD5006 |
Approved |
0.6878 |
Remote Similarity |
NPD5005 |
Approved |
0.6872 |
Remote Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.6866 |
Remote Similarity |
NPD4363 |
Phase 3 |
0.6866 |
Remote Similarity |
NPD4360 |
Phase 2 |
0.686 |
Remote Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.6857 |
Remote Similarity |
NPD7097 |
Phase 1 |
0.6851 |
Remote Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.6845 |
Remote Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.6842 |
Remote Similarity |
NPD5710 |
Approved |
0.6842 |
Remote Similarity |
NPD5711 |
Approved |
0.6842 |
Remote Similarity |
NPD7229 |
Phase 3 |
0.6839 |
Remote Similarity |
NPD5124 |
Phase 1 |
0.6839 |
Remote Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.6834
|
Remote Similarity |
NPD4287 |
Approved |